Back to RecallTracker
Health Canada Health products

Archived - New CONTRAINDICATION regarding ergotamine- and dihydroergotamine-containing drugs: Risk of Cerebral and/or Peripheral Ischemia - Novartis Pharmaceuticals Canada Inc

Issued January 30, 2003